期刊文献+

2型糖尿病患者血浆神经肽Y、B型钠尿肽、脂联素水平的变化 被引量:6

下载PDF
导出
摘要 糖尿病合并高血压微血管病变的患者通常病史5~10年要考虑可能并发糖尿病肾病和心脑血管疾病,其发病机制十分复杂。已有较多的报道研究血浆神经肽Y(NPY)或B型钠尿肽(BNP)或脂联素与糖尿病的关系,但三者在血液中的含量之间的相互关系还未见报道。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第12期2894-2895,共2页 Chinese Journal of Gerontology
基金 江苏省高校自然科学研究基金(No.10KJB310003) 江苏大学高级专业人才科研启动基金(No.08JDG019)
  • 相关文献

参考文献7

  • 1Frankish HM, Dryden S, Hopkins D ,et al. Neuropeptide Y,the hypothala-mus ,and diabetes:insights into the central control of metabolism [J].Peptides, 1995;16(4):757-71.
  • 2Moran TH,Bi S. Hyperphagia and obesity in OLETF rats lacking CCK-1receptors[ J]. Philos Trans R Soc Lond B Biol Sci,2006;361(1471 ):1211-8.
  • 3Zha JS,Zhang Y, Wang Q, et al. Plasma NPY and neurotensin(NT) intype 2 diabetes patients research of the relationship[ J]. Labeled Immuno-assays Clin Med,2001;9(3):174-5.
  • 4Foley RN,Parfrey PS,Samak MJ. Clinical epidemiology of cardiovasculardisease in chronic renal disease [ J] . Am J Kidney Dis,1998;32(3 ):112-9.
  • 5Yang JW, Kim JS. Relationship between serum brain natriuretic peptideand heart function in patients with chronic kidney disease[ J] . Korean JIntern Med,2008;23(4):191-200.
  • 6Zhou Q,Wu XM. The relationship among adiponectin,obesity,insulin re-sistance and type 2 diabetes [J].Int J Laboratory Med,2008;29(10):899-900.
  • 7Yang WS,Jeng CY, Wu TJ,ef al. Synthetic peroxisome proliferator-activa-ted receptor-gamma agonist,rosiglitazone,increases plasma levels of adi-ponectin in type 2 diabetic patients[ J]. Diabetes Care,2002;25(2 ):376-80.

同被引文献84

  • 1刘超.脂联素和2型糖尿病相关性的研究进展[J].医学临床研究,2012,29(6). 被引量:2
  • 2宋克群,于慧玲,冯长顺,戴华,李幼阳,蔡兰平,唐丽君,贾小清,任素琴,薛长勇.老年男性代谢综合征患者体脂分布[J].中国老年学杂志,2014,34(8):2282-2283. 被引量:4
  • 3Lilja M, Rolandsson O, Norberg M, et al. The impact of Leptin and adiponectin on incident type 2 diabetes is modified by sex and insu- lin resistance[ J]. Metab Syndr Relat Diserd, 2012, 10:143 - 151.
  • 4Gaikwad A, Biju KC, Muthal PL, et al. Role of neuropeptideY in the regulation of gonadotrop in releasing hormone system in the fore- brain of Clarias batrachus (Linn) : Immunocytochemistry and high performance liquid chrom spectrometric analysis[ J]. Neuroscience, 2005, 133:267 -279.
  • 5Bruinstroop E, Pei L, Ackermans MT, et al. Hypothalamic neu- ropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system [ J ]. Diabetes, 2012, 61 :1043 - 1050.
  • 6Skasstrand H, Dablin LB, Lemmark A, et al. Neuropeptide Y and autoantibodies in patients with long-term type 1 and type 2 diabetes and neuropathy [ J ]. J Diabetes Complications, 2013, 27 : 609 - 617.
  • 7AL-Aazzam SL, Alkhateeb AM, Alzoubi KH, et al. Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes [ J ]. Exp Ther Med, 2013, 6 : 1565 - 1569.
  • 8Ladyman SR, Fieldwick DM, Grattan DR. Suppression of leptin-in- duced hypothalamic JAK/STAT signalling and feeding response dur- ing pregnancy in the mouse [ J ]. Reproduction, 2012, 144 : 83 -90.
  • 9Dalvi PS, Erbiceanu FD, Irwin DM, et al. Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons[ J ]. Mol Endoerino, 2012, 26 : 1339 - 1355.
  • 10Nazarians-Armavil A, Menchella JA, Belsham DD. Cellular insulin resistance disrupts lepfin-mediated control of neuronal signaling and transcription[J]. Mol Endocrinol, 2013, 27:990 - 1003.

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部